TGF-β could also modulate the expression of CD36, since inhibition of TGF-β in THP-1 cell-derived macrophages treated with a eutopic endometrial homogenate, improved the expression of CD36, therefore TGF-β could be a potential therapeutic target for the treatment of endometriosis [30]. The gene discussed is TGFB1; the disease is endometriosis.